Emerging data on rifampicin pharmacokinetics and approaches to optimal dosing in children with tuberculosis-Reference-Cited by-同舟云学术

Emerging data on rifampicin pharmacokinetics and approaches to optimal dosing in children with tuberculosis

Published:2022-02-01 Issue:2 Volume:15 Page:161-174
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Radtke Kendra K.¹,Svensson Elin M.²³,van der Laan Louvina E.⁴,Hesseling Anneke C.⁴,Savic Radojka M.¹,Garcia-Prats Anthony J.⁴⁵^ORCID

Affiliation:

1. Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA

2. Department of Pharmacy, Radboud University Medical Center, Nijmegen, The Netherlands

3. Department of Pharmacy, Uppsala University, Uppsala, Sweden

4. Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Stellenbosch University, Tygerberg, South Africa

5. Department of Pediatrics, University of Wisconsin, Madison, WI, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2022.2053110

Reference87 articles.

1. World Health Organization. Global tuberculosis report 2020 Geneva: WHO; 2020 [2021 Jan 26]. Available from: https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf

2. RifamycinMode of Action, Resistance, and Biosynthesis

3. Rifampin U.S. Food and Drug Administration (FDA) Label November 2010 [2020 Aug 3]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/050420s073,050627s012lbl.pdf

4. Human arylacetamide deacetylase is responsible for deacetylation of rifamycins: Rifampicin, rifabutin, and rifapentine

5. Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic Extraction

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Towards Shorter, Child-Friendly Regimens for Treatment of Tuberculosis Disease and Infection in Children;Pediatric Infectious Disease Journal;2022-10-03